drugset / Trial / NCT00000236

Buprenorphine Pharmacology Related to Addiction Treatment - 18

NCT00000236 ↗

Treatment

Summary

The purpose of this study is to examine the interactions between buprenorphine and naltrexone, and to assess how they may directly impact the clinical issues involving: transferring patients from buprenorphine to naltrexone, developing a non-abusable form of buprenorphine, and enhancing patient acceptability of naltrexone.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Buprenorphine Other / unclassified — —
Background Naloxone Small molecule — —